AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
69 hedge funds and large institutions have $372M invested in Aimmune Therapeutics in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
22% less capital invested
Capital invested by funds: $476M → $372M (-$103M)
Holders
69
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$12.3M | |
| 2 | +$7.24M | |
| 3 | +$7.07M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$6.82M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.76M |
Top Sellers
| 1 | -$16M | |
| 2 | -$642K | |
| 3 | -$516K | |
| 4 |
FAM
Fred Alger Management
New York
|
-$318K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$233K |